Vollenweider FX

Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry and University of Zurich, Zurich, Switzerland.

35 papers · 3 preprints · ORCID

ArticlePsilocybin

Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice.

Hogg DE, Romanos J, Albiez J +8

Europe PMC2026
ArticlePsilocybin

Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.

Urban MM, Zillich L, Rieser NM +5

Europe PMC2026
ArticleMDMA

Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.

Ramaekers JG, Kuypers KPC, Vollenweider FX

Europe PMC2026
ArticlePsilocybin

An international mega-analysis of psychedelic drug effects on brain circuit function.

Girn M, Doss MK, Roseman L +24

Europe PMC2026
PreprintPsilocybin

Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity

Allohverdi SG, Soltanzadeh M, Schmidt A +5

Europe PMC2025
ArticlePsilocybin

Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm.

Soltanzadeh M, Wang Z, Allohverdi SG +4

Europe PMC2026
PreprintPsilocybin

Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder

Urban MM, Zillich L, Rieser NM +5

Europe PMC2025
ArticlePsychedelics

Correction: Neural mechanisms of psychedelic visual imagery.

Stoliker D, Preller KH, Novelli L +4

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

Rieser NM, Bitar R, Halm S +14

Europe PMC2025
ArticlePsilocybin

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Yaden DB, Graziosi M, Owen AM +39

Europe PMC2025
ArticlePsilocybin

Psilocybin increases emotional empathy in patients with major depression.

Jungwirth J, von Rotz R, Dziobek I +2

Europe PMC2025
ArticlePsilocybin

Neural mechanisms of psychedelic visual imagery.

Stoliker D, Preller KH, Novelli L +4

Europe PMC2025
ArticlePsilocybin

The influence of psilocybin on subconscious and conscious emotional learning.

Casanova AF, Ort A, Smallridge JW +3

Europe PMC2024
ArticlePsilocybin

<i>In vitro</i> and <i>in vivo</i> metabolism of psilocybin's active metabolite psilocin.

Thomann J, Kolaczynska KE, Stoeckmann OV +7

Europe PMC2024
ArticleKetamine

Ketamine induces multiple individually distinct whole-brain functional connectivity signatures.

Moujaes F, Ji JL, Rahmati M +23

Europe PMC2024
ArticlePsilocybin

Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.

Singer B, Meling D, Hirsch-Hoffmann M +7

Europe PMC2024
ArticlePsilocybin

Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.

Stoliker D, Novelli L, Vollenweider FX +3

Europe PMC2024
ArticlePsilocybin

Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.

Rieser NM, Gubser LP, Moujaes F +5

Europe PMC2023
ArticlePsilocybin

Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.

Moujaes F, Rieser NM, Phillips C +9

Europe PMC2024
ArticlePsilocybin

TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.

Ort A, Smallridge JW, Sarasso S +7

Europe PMC2023
ArticlePsilocybin

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.

von Rotz R, Schindowski EM, Jungwirth J +9

Europe PMC2023
ArticlePsychedelics

Psychedelics and fNIRS neuroimaging: exploring new opportunities.

Scholkmann F, Vollenweider FX

Europe PMC2023
PreprintPsilocybin

Neural mechanisms of psychedelic visual imagery

Stoliker D, Preller KH, Novelli L +4

Europe PMC2022
ArticleLSD

Effective Connectivity of Functionally Anticorrelated Networks Under Lysergic Acid Diethylamide.

Stoliker D, Novelli L, Vollenweider FX +3

Europe PMC2023
ArticlePsychedelics

A neurobiological perspective on social influence: Serotonin and social adaptation.

Duerler P, Vollenweider FX, Preller KH

Europe PMC2022
ArticlePsychedelics

Classic Psychedelic Drugs: Update on Biological Mechanisms.

Vollenweider FX, Smallridge JW

Europe PMC2022
ArticleLSD

Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD.

Burt JB, Preller KH, Demirtas M +5

Europe PMC2021
ArticleLSD

LSD and ketanserin and their impact on the human autonomic nervous system.

Olbrich S, Preller KH, Vollenweider FX

Europe PMC2021
ArticlePsilocybin

Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.

Lewis CR, Preller KH, Braden BB +2

Europe PMC2020
ArticlePsychedelics

Modulation of Social Cognition <i>via</i> Hallucinogens and "Entactogens".

Preller KH, Vollenweider FX

Europe PMC2019
ArticleLSD

Effective connectivity changes in LSD-induced altered states of consciousness in humans.

Preller KH, Razi A, Zeidman P +3

Europe PMC2019
ArticleLSD

Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music.

Barrett FS, Preller KH, Herdener M +2

Europe PMC2018
ArticlePsilocybin

Phenomenology, Structure, and Dynamic of Psychedelic States.

Preller KH, Vollenweider FX

Europe PMC2018
ArticlePsilocybin

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.

Kometer M, Vollenweider FX

Europe PMC2018
ArticleLSD

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.

Kraehenmann R, Pokorny D, Aicher H +5

Europe PMC2017
ArticlePsilocybin

Effect of Psilocybin on Empathy and Moral Decision-Making.

Pokorny T, Preller KH, Kometer M +2

Europe PMC2017
ArticlePsilocybin

Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Quednow BB, Kometer M, Geyer MA +1

Europe PMC2012
ArticlePsilocybin

Brain mechanisms of hallucinogens and entactogens.

Vollenweider FX

Europe PMC2001